Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.23.1
Segment Information (Tables)
3 Months Ended
Apr. 01, 2023
Segment Reporting [Abstract]  
Schedule of Segment Information

The following tables present our segment information for the 13 weeks ended April 1, 2023 and April 2, 2022 (in $000's):

 

 

Thirteen Weeks Ended

 

 

April 1, 2023

 

 

April 2, 2022

 

Revenues

 

 

 

 

 

Biotechnology

$

 

 

$

 

Discontinued operations

 

3,795

 

 

 

9,324

 

Total Revenues

$

3,795

 

 

$

9,324

 

Gross profit

 

 

 

 

 

Biotechnology

$

 

 

$

 

Discontinued operations

 

(197

)

 

 

1,853

 

Total Gross profit

$

(197

)

 

$

1,853

 

Operating loss

 

 

 

 

 

Biotechnology

$

(1,099

)

 

$

(681

)

Discontinued operations

 

14,158

 

 

 

(410

)

Total Operating loss

$

13,059

 

 

$

(1,091

)

Depreciation and amortization

 

 

 

 

 

Biotechnology

$

364

 

 

$

 

Discontinued operations

 

96

 

 

 

133

 

Total Depreciation and amortization

$

460

 

 

$

133

 

Interest (income) expense, net

 

 

 

 

 

Biotechnology

$

(475

)

 

$

2

 

Discontinued operations

 

181

 

 

 

190

 

Total Interest expense, net

$

(294

)

 

$

192

 

Net income (loss) before income taxes

 

 

 

 

 

Biotechnology

$

(867

)

 

$

2,619

 

Discontinued operations

 

13,976

 

 

 

(1,405

)

Total Net income before income taxes

$

13,109

 

 

$

1,214